1,312
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of muscle strength and quality in North African patients with chronic hepatitis B: A pilot case control study

, , , , , , & ORCID Icon show all
Article: 2204564 | Received 16 Jan 2023, Accepted 16 Apr 2023, Published online: 25 Apr 2023

References

  • Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):S13–14.
  • Zampino R, Boemio A, Sagnelli C, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21(42):11941–11953. DOI:10.3748/wjg.v21.i42.11941
  • Dienstag JL. Hepatitis B as an immune complex disease. Semin Liver Dis. 1981;1(1):45–57.
  • Hiraoka A, Michitaka K, Ueki H, et al. Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2016;28(8):940–947. DOI:10.1097/MEG.0000000000000661
  • Galant LH, Forgiarini Junior LA, Dias AS, et al. Functional status, respiratory muscle strength, and quality of life in patients with cirrhosis. Rev Bras Fisioter. 2012;16(1):30–34.
  • Faustini Pereira JL, Galant LH, Rossi D, et al. Functional capacity, respiratory muscle strength, and oxygen consumption predict mortality in patients with cirrhosis. Can J Gastroenterol Hepatol. 2016;2016:6940374.
  • Capasso M, Di Muzio A, Comar M, et al. The association of chronic hepatitis B and myopathy. Neurology. 2006;67(8):1467–1469. DOI:10.1212/01.wnl.0000240078.47020.5e
  • Andersen H, Borre M, Jakobsen J, et al. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology. 1998;27(5):1200–1206.
  • Mechtcheriakov S, Graziadei IW, Kugener A, et al. Motor dysfunction in patients with liver cirrhosis: impairment of handwriting. J Neurol. 2006;253(3):349–356. DOI:10.1007/s00415-005-0995-5
  • Butz M, Timmermann L, Braun M, et al. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand. 2010;122(1):27–35. DOI:10.1111/j.1600-0404.2009.01246.x
  • Bohannon RW, Wang YC, Bubela D, et al. Handgrip Strength: a Population-based study of norms and age trajectories for 3- to 17-year-olds. Pediatr Phys Ther. 2017;29(2):118–123.
  • Bohannon RW. Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care. 2015;18(5):465–470.
  • Beseler MR, Rubio C, Duarte E, et al. Clinical effectiveness of grip strength in predicting ambulation of elderly inpatients. Clin Interv Aging. 2014;9:1873–1877.
  • Rolland Y, Lauwers-Cances V, Pahor M, et al. Muscle strength in obese elderly women: effect of recreational physical activity in a cross-sectional study. Am J Clin Nutr. 2004;79(4):552–557.
  • Mearns BM. Risk factors: hand grip strength predicts cardiovascular risk. Nat Rev Cardiol. 2015;12(7):379.
  • Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985). 2003;95(5):1851–1860. DOI:10.1152/japplphysiol.00246.2003
  • Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the prospective urban rural epidemiology (PURE) study. Lancet. 2015;386(9990):266–273. DOI:10.1016/S0140-6736(14)62000-6
  • Ling CH, Taekema D, de Craen AJ, et al. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ. 2010;182(5):429–435.
  • Chen PJ, Lin MH, Peng LN, et al. Predicting cause-specific mortality of older men living in the Veterans home by handgrip strength and walking speed: a 3-year, prospective cohort study in Taiwan. J Am Med Dir Assoc. 2012;13(6):517–521. DOI:10.1016/j.jamda.2012.02.002
  • Dong R, Wang X, Guo Q, et al. Clinical relevance of different handgrip strength indexes and mobility limitation in the elderly adults. J Gerontol A Biol Sci Med Sci. 2016;71(1):96–102. DOI:10.1093/gerona/glv168
  • Sayer AA, Kirkwood TB. Grip strength and mortality: a biomarker of ageing? Lancet. 2015;386(9990):226–227.
  • Nofuji Y, Shinkai S, Taniguchi Y, et al. Associations of walking speed, grip strength, and standing balance with total and cause-specific mortality in a general population of Japanese elders. J Am Med Dir Assoc. 2016;17(2):184 e1–7. DOI:10.1016/j.jamda.2015.11.003
  • Nishikawa H, Shiraki M, Hiramatsu A, et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016;46(10):951–963.
  • Hiraoka A, Tamura R, Oka M, et al. Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independently. Hepatol Res. 2019;49(7):823–829. DOI:10.1111/hepr.13322
  • Itoh S, Shirabe K, Yoshizumi T, et al. Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experience. Hepatol Res. 2016;46(4):292–297. DOI:10.1111/hepr.12537
  • Nagamatsu A, Kawaguchi T, Hirota K, et al. Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma. Hepatol Res. 2019;49(12):1427–1440. DOI:10.1111/hepr.13405
  • Nishikawa H, Enomoto H, Yoh K, et al. Health-related quality of life in chronic liver diseases: a strong impact of hand grip strength. J Clin Med. 2018;7(12):553. DOI:10.3390/jcm7120553
  • Sharma P, Rauf A, Matin A, et al. Handgrip strength as an important bed side tool to assess malnutrition in patient with liver disease. J Clin Exp Hepatol. 2017;7(1):16–22.
  • Oktayoğlu P, Tekin R, Çağlayan M, et al. Assessment of hand functions in patients with chronic hepatitis B. Erciyes Med J. 2014;36(2):58–61. DOI:10.5152/etd.2014.8416
  • Alsoufi B. Statistical versus clinical significance. J Thorac Cardiovasc Surg. 2018;155(1):344–345.
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. DOI:10.1093/ageing/afq034
  • Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307. DOI:10.1016/j.jamda.2019.12.012
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. DOI:10.1093/ageing/afy169
  • Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232–1244.
  • Lee YH, Kim SU, Song K, et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008-2011). Hepatology. 2016;63(3):776–786. DOI:10.1002/hep.28376
  • Han E, Lee YH, Kim BK, et al. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B. Aliment Pharmacol Ther. 2018;48(3):300–312. DOI:10.1111/apt.14843
  • Kang SH, Kim MY, Baik SK. The impact of sarcopenia and its rate of change on prognostic value of liver cirrhosis. J Korean Med Sci. 2018;33(50):e334.
  • Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc. 2012;13(2):121–126. DOI:10.1016/j.jamda.2011.07.004
  • Bergaoui J, Latiri I, Ben Saad H. Deficiency, incapacity and social disadvantage of patients with chronic hepatitis B: a case-control study. Tunis Med. 2021;99(7):682–692.
  • European association for study of liver. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237–264.
  • Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol. 2010;16(4):501–507.
  • Viral hepatitis B: update of Tunisian recommendations of the Tunisian society of gastroenterology and the Tunisian society of infectious pathology. 2019. [cited April 8, 2023]; Available from: https://www.infectiologie.org.tn/pdf_ppt_docs/recommandations/1576619564.pdf.
  • Serhier Z, Bendahhou K, Ben Abdelaziz A, et al. Methodological sheet n degrees 1: how to calculate the size of a sample for an observational study? Tunis Med. 2020;98(1):1–7.
  • Berk PD, Popper H. Fulminant hepatic failure. Am J Gastroenterol. 1978;69(3 Pt 2):349–400.
  • Maimone S, Calvaruso V, Pleguezuelo M, et al. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. J Viral Hepat. 2009;16(11):769–774. DOI:10.1111/j.1365-2893.2009.01120.x
  • Strader DB, Wright T, Thomas DL, et al. American association for the study of liver diseases. diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4):1147–1171.
  • Abdelghani A, Ben Saad H, Ben Hassen I, et al. Evaluation of the deficiency and the submaximal exercise capacity in obstructive sleep apnoea patients. Rev Mal Respir. 2010;27(3):266–274. DOI:10.1016/j.rmr.2010.02.004
  • Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med. 2013;159(5) ITC3-1-ITC3-15; quiz ITC3-6. DOI:10.7326/0003-4819-159-5-201309030-01003
  • Janssen I, Heymsfield SB, Baumgartner RN, et al. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985). 2000;89(2):465–471.
  • Heymsfield SB, Smith R, Aulet M, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr. 1990;52(2):214–218. DOI:10.1093/ajcn/52.2.214.
  • Wang ZM, Visser M, Ma R, et al. Skeletal muscle mass: evaluation of neutron activation and dual-energy X-ray absorptiometry methods. J Appl Physiol (1985). 1996;80(3):824–831. DOI:10.1152/jappl.1996.80.3.824
  • Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31(4):643–650.
  • Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):567–575. DOI:10.1093/gerona/glu023
  • Cederholm T, Jensen GL, Correia M, et al. GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. DOI:10.1016/j.clnu.2018.08.002
  • Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. DOI:10.1016/j.jamda.2013.11.025
  • Gould H, Brennan SL, Kotowicz MA, et al. Total and appendicular lean mass reference ranges for Australian men and women: the Geelong osteoporosis study. Calcif Tissue Int. 2014;94(4):363–372.
  • Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763. DOI:10.1093/oxfordjournals.aje.a009520
  • Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–558. DOI:10.1093/gerona/glu010
  • Lawman HG, Troiano RP, Perna FM, et al. Associations of relative handgrip strength and cardiovascular disease biomarkers in U.S. Adults, 2011-2012. Am J Prev Med. 2016;50(6):677–683.
  • Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS ONE. 2014;9(12):e113637. DOI:10.1371/journal.pone.0113637
  • Olejnik S, Algina J. Measures of effect size for comparative studies: applications, interpretations, and limitations. Contemp Educ Psychol. 2000;25(3):241–286.
  • Wheaton FV, Crimmins EM. Female disability disadvantage: a global perspective on sex differences in physical function and disability. Ageing Soc. 2016;36(6):1136–1156.
  • Lau EM, Lynn HS, Woo JW, et al. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci. 2005;60(2):213–216.
  • Visser M, Harris TB, Langlois J, et al. Body fat and skeletal muscle mass in relation to physical disability in very old men and women of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci. 1998;53(3):M214–21. DOI:10.1093/gerona/53A.3.M214
  • Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):56–62.
  • Incel NA, Ceceli E, Durukan PB, et al. Grip strength: effect of hand dominance. Singapore Med J. 2002;43(5):234–237.
  • Cohen L. Magnesium and liver cirrhosis: a hypothesis. Magnesium. 1985;4(1):1–4.
  • Zoli M, Marchesini G, Dondi C, et al. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin Sci (Lond). 1982;62(6):683–686.
  • Ebadi M, Bhanji RA, Mazurak VC, et al. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol. 2019;54(10):845–859.
  • Hiraoka A, Michitaka K, Izumoto H, et al. Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over a 2-year observation period. Hepatol Res. 2018;48(7):502–508. DOI:10.1111/hepr.13051
  • Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423–429. DOI:10.1093/ageing/afr051
  • Fowles J, Roy J, Clarke J, et al. Are the fittest Canadian adults the healthiest? Health Rep. 2014;25(5):13–18.
  • Keevil VL, Khaw KT. Overadjustment in regression analyses: considerations when evaluating relationships between body mass index, muscle strength, and body size. J Gerontol A Biol Sci Med Sci. 2014;69(5):616–617.
  • Tracy BL, Ivey FM, Hurlbut D, et al. Muscle quality. II. Effects of strength training in 65- to 75-yr-old men and women. J Appl Physiol (1985). 1999;86(1):195–201. DOI:10.1152/jappl.1999.86.1.195
  • Li D, Guo G, Xia L, et al. Relative handgrip strength is inversely associated with metabolic profile and metabolic disease in the general population in China. Front Physiol. 2018;9:59.
  • Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–635. DOI:10.1016/S1470-2045(08)70153-0
  • Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693–700.
  • Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059–1064. DOI:10.1093/gerona/61.10.1059
  • Choquette S, Bouchard DR, Doyon CY, et al. Relative strength as a determinant of mobility in elders 67-84 years of age. a nuage study: nutrition as a determinant of successful aging. J Nutr Health Aging. 2010;14(3):190–195.
  • Straight C, Brady A, Schmidt M, et al. Comparison of laboratory-and field-based estimates of muscle quality for predicting physical function in older women. J Aging Res Clin Pract. 2013;2(3):276–279.
  • Mascha EJ, Vetter TR. Significance, errors, power, and sample size: the blocking and tackling of statistics. Anesth Analg. 2018;126(2):691–698.
  • Yaddanapudi LN. The American statistical association statement on P-values explained. J Anaesthesiol Clin Pharmacol. 2016;32(4):421–423.
  • Lu X, Chu H, Wang L, et al. Age- and sex-related differences in muscle strength and physical performance in older Chinese. Aging Clin Exp Res. 2020;32(5):877–883. DOI:10.1007/s40520-019-01263-x
  • Swan L, Warters A, O’Sullivan M. Socioeconomic disadvantage is associated with probable sarcopenia in community-dwelling older adults: findings from the English longitudinal study of ageing. J Frailty Aging. 2022;11(4):398–406.
  • Gnyawali B, Pusateri A, Nickerson A, et al. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol. 2022;28(29):3793–3802.
  • Diallo S, Bassène ML, Gueye MN, et al. Viral hepatitis B: clinical, paraclinical and evolutionary features within the hepato gastroenterology department at the Aristide Le Dantec Hospital: about 728 cases. Pan Afr Med J. 2018;31:82.
  • Mijnarends DM, Meijers JM, Halfens RJ, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14(3):170–178. DOI:10.1016/j.jamda.2012.10.009
  • Malmstrom TK, Miller DK, Simonsick EM, et al. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36.
  • Hamaguchi Y, Kaido T, Okumura S, et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation. 2017;101(3):565–574. DOI:10.1097/TP.0000000000001587
  • Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52(5):719–724. DOI:10.1111/j.1532-5415.2004.52208.x
  • Anemia: situation in Tunisia. [cited April 8, 2023]; Available from: http://www.nutrition.rns.tn/mcanemie/situation/situation.htm